to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity to prevent or treat motion sickness, see below: adults and children 12 years and over take 1 to 2 chewable tablets every 4-6 hours do not take more than 8 chewable tablets in 24 hours, or as directed by a doctor children 6 to under 12 years give 1/2 to 1 chewable tablet every 6-8 hours do not give more than 3 chewable...
Phenylketonurics: contains phenylaline 0.84 mg per tablet store at room tempurature 20°- 25°C (68°-77°F) do not use if pouch is opened see bottom of this panel for lot number and expiration date
Drug Facts
Dimenhydrinate 50 mg
Antiemetic
for prevention and treatment of these symptoms associated with motion sickness:
Do not give to children under 2 years of age unless directed by a doctor
Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers
If pregnant or breast-feeding, ask a doctor before use.
Keep out of reach of children.
In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.
| adults and children 12 years and over |
|
| children 6 to under 12 years |
|
| children 2 to under 6 years |
|
anhydrous citric acid, aspartame, FD&C yellow #6 aluminum lake, flavors, magnesium stearate, maltodextrin, methacrylic acid copolymer, modified starch, sorbitol
call 1-800-382-7219
Dist By:
Medtech Products, Inc. Tarrytown, NY 10591
Product Repackaged and Distributed
with permission of manufacturer by:
Select Corporation Carrollton, TX 75007
#1
Pharmacist
Recommended
BRAND
DIMENHYDRINATE
TABLETS / ANTIEMETIC
Dramamine®
motion sickness
CHEWABLE
Dual Action:
Prevents & Relieves Nausea,
Dizziness and Vomiting
TO OPEN
PUSH IN TAB AND PULL OUT
25 Packets of 2 Orange Flavor Tablets
(50 mg each)
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52904-962-04 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1905-111a-e063-dadaa90a10e2 | Dramamine ® |
| 52904-962-25 | 2024-01-30 | C162847 | 48780-1 | 1030e365-1905-111a-e063-dadaa90a10e2 | Dramamine ® |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52904-962-04 | Dramamine | 2 in 1 POUCH | TABLET | 2 | 1 | |
| 52904-962-04 | Dramamine | 1 in 1 BLISTER PACK | TABLET | 1 | 1 | |
| 52904-962-25 | Dramamine | 25 in 1 CARTON | TABLET | 25 | 1 | |
| 52904-962-25 | Dramamine | 2 in 1 POUCH | TABLET | 2 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 52904-962 | 52904-962-04, 52904-962-25 |
| 63029-901 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIMENHYDRINATE | JB937PER5C | ACTIB |
| silicon dioxide | ETJ7Z6XBU4 | IACT |
| croscarmellose sodium | M28OL1HH48 | IACT |
| lactose, unspecified form | J2B2A4N98G | IACT |
| magnesium stearate | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dramamine Original Formula | DIMENHYDRINATE | Medtech Products Inc. | f9302a5a-295a-4501-9332-e3f5eb387362 | 2025-10-23 | Warnings | 63029-901 |
| 9bca7cdc-8f19-4c96-acfa-6b332faaf7c0 | ec76597c-eb6a-4025-9d64-fb79c2daca51 | 2022-04-14 | Warnings | 9bca7cdc-8f19-4c96-acfa-6b332faaf7c0 ec76597c-eb6a-4025-9d64-fb79c2daca51 |
Adverse event summaries are temporarily unavailable. Other product information remains available.